Cdk1

From WikiMD's Wellness Encyclopedia

Cdk1[edit | edit source]

Cdk1 (Cyclin-dependent kinase 1) is a highly conserved protein that plays a crucial role in the regulation of the cell cycle. It is a serine/threonine kinase that is essential for the transition from the G2 phase to the M phase (mitosis) of the cell cycle. Cdk1 is also known as cell division cycle 2 (Cdc2) in some organisms.

Structure[edit | edit source]

Cdk1 is a member of the cyclin-dependent kinase family, which requires association with a regulatory subunit called a cyclin to become active. The active complex formed by Cdk1 and cyclin is responsible for phosphorylating various substrates that drive the cell cycle forward.

Function[edit | edit source]

Cdk1 is primarily involved in the control of the cell cycle. It is activated at the onset of mitosis and is responsible for initiating several processes that lead to cell division. These processes include:

  • Chromosome condensation
  • Nuclear envelope breakdown
  • Mitotic spindle formation
  • Chromosome alignment and segregation

Cdk1 activity is tightly regulated by phosphorylation and dephosphorylation events, as well as by the binding of specific cyclins.

Regulation[edit | edit source]

The activity of Cdk1 is regulated by several mechanisms:

  • Cyclin binding: Cdk1 must bind to a cyclin, such as cyclin B, to become active. The levels of cyclins fluctuate throughout the cell cycle, providing a mechanism for temporal regulation of Cdk1 activity.
  • Phosphorylation: Cdk1 is regulated by phosphorylation at specific residues. For example, phosphorylation of threonine 161 is required for activation, while phosphorylation of threonine 14 and tyrosine 15 inhibits its activity.
  • Dephosphorylation: The phosphatase Cdc25 removes inhibitory phosphates from Cdk1, activating it at the appropriate time in the cell cycle.

Clinical Significance[edit | edit source]

Dysregulation of Cdk1 activity can lead to uncontrolled cell division and is implicated in the development of cancer. As a result, Cdk1 is a target for cancer therapy, and inhibitors of Cdk1 are being investigated as potential anticancer agents.

Research[edit | edit source]

Research on Cdk1 continues to uncover its roles in cell cycle regulation and its potential as a therapeutic target. Studies have shown that Cdk1 is not only crucial for mitosis but also plays roles in DNA repair and apoptosis.

See Also[edit | edit source]

References[edit | edit source]

  • Morgan, D. O. (2007). The Cell Cycle: Principles of Control. Oxford University Press.
  • Nurse, P. (2000). A long twentieth century of the cell cycle and beyond. Cell, 100(1), 71-78.

External Links[edit | edit source]

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD